NCT05505396View on ClinicalTrials.gov

Hyperglycaemia and Hyperlactataemia in Patients With Severe Acute Brain Injury

CompletedOBSERVATIONAL
Enrollment

459

Participants

Timeline

Start Date

October 24, 2022

Primary Completion Date

April 30, 2024

Study Completion Date

October 30, 2024

Conditions
Acute Brain InjuryHyperglycemiaHyperlactatemia
Interventions
OTHER

Sampling of blood and cerebrospinal fluid

Blood HbA1c, insulin, C-peptide and IL-6 measured at admission. Glucose and lactate measured every 4 hours during intensive care stay. Daily sampling of CSV analysed for glucose and lactate in patients with EVD.

Trial Locations (1)

Unknown

Department of Neuroanesthesiology and Neurointensive Care, Rigshospitalet, Copenhagen

All Listed Sponsors
lead

Rigshospitalet, Denmark

OTHER